Skip navigation

Food Standards Agency

Safer food better business banner

AZ-Directory What's New

Migration of bisphenol A from can coatings into food - Detailed points raised in the consultation

Monday 17 September 2001

Some factual points or questions on related issues were also provided (comments from the Food Standards Agency are in bold).

'The Committee's attention was drawn to WWF's comments on the COT's statement on bisphenol A (BPA). The Committee's statement was drafted in response to the results of a survey by the Food Standards Agency (FSA) on the migration of BPA from can coatings into retail samples of canned food.

The Committee noted that uncertainties exist in the scientific understanding of potential endocrine effects of BPA and therefore paid particular attention to this activity in their risk assessment. The WWF response to COT's statement points to a number of risk management issues. The remit of the COT is risk assessment and does not generally extend to advice on risk management.

The Committee recognised from the outset that, the Scientific Committee for Food's (SCF) TDI for BPA was set during 1986 on the basis of long-term studies before the potential endocrine modulating activity of this compound was proposed. The SCF is due to review the TDI for BPA in the near future.

In order to inform its review of scientific data, the COT was made fully aware of the draft report of the Health and Safety Executive (HSE) on BPA and the new study which provides the basis for classification of BPA as toxic to reproduction. The Committee was also made aware of the report of NTP's Peer review of low dose effects of endocrine disrupters. It is noteworthy that most of the studies referred to by WWF as not being included in the Committee's review were addressed at paragraph 11 of the statement.

Notwithstanding reports of apparent low-dose effects of BPA, the COT took the view, supported by the best scientific evidence available at the time of its review, that it is not appropriate to base human health risk assessment on the current reports. The Committee conclusions were based on four reasons which were explained in detail in the statement. In summary these were;

These points were also noted in NTP's peer review of low-dose effects, which concluded "the Subpanel is not persuaded that a low dose effect of BPA has been conclusively established as a general reproducible finding".

In conclusion, the COT fully acknowledged the uncertainties that exist in the scientific understanding of potential endocrine effects of BPA. Nevertheless, on the basis of all the available evidence, the Committee saw no reason for consumers to change their source of foodstuffs as a result of the survey findings. However as a matter of prudence, the Committee noted that this toxicological advice should be reviewed as further scientific evidence emerges on possible low-dose effects of endocrine modulating substances.'

Tell a Friend

Printer friendly

Contact us

Get alerts

FSA online

Find out about our different types of content

Change Text Only Settings

Graphic version of this page